These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 23117077)

  • 1. The need for expanded monitoring of adverse events in behavioral health clinical trials.
    Peterson AL; Roache JD; Raj J; Young-McCaughan S;
    Contemp Clin Trials; 2013 Jan; 34(1):152-4. PubMed ID: 23117077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data and safety monitoring in social behavioral intervention trials: the REACH II experience.
    Czaja SJ; Schulz R; Belle SH; Burgio LD; Armstrong N; Gitlin LN; Coon DW; Martindale-Adams J; Klinger J; Stahl SM
    Clin Trials; 2006; 3(2):107-18. PubMed ID: 16773953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Expert Consensus Guideline Series. Treatment of behavioral emergencies.
    Allen MH; Currier GW; Hughes DH; Reyes-Harde M; Docherty JP;
    Postgrad Med; 2001 May; (Spec No):1-88; quiz 89-90. PubMed ID: 11500996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Institutional review boards (IRBs) and working with adverse event reports.
    Maloney DM
    Hum Res Rep; 2005 Dec; 20(12):1-3. PubMed ID: 16607708
    [No Abstract]   [Full Text] [Related]  

  • 9. Centralized medical monitoring in phase III clinical trials: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience.
    Soran A; Nesbitt L; Mamounas EP; Lembersky B; Bryant J; Anderson S; Brown A; Passarello M
    Clin Trials; 2006; 3(5):478-85. PubMed ID: 17060221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-based interventions for neurologic conditions: ethical challenges for early human trials.
    Mathews DJ; Sugarman J; Bok H; Blass DM; Coyle JT; Duggan P; Finkel J; Greely HT; Hillis A; Hoke A; Johnson R; Johnston M; Kahn J; Kerr D; Kurtzberg J; Liao SM; McDonald JW; McKhann G; Nelson KB; Rao M; Regenberg A; Siegel AW; Smith K; Solter D; Song H; Vescovi A; Young W; Gearhart JD; Faden R
    Neurology; 2008 Jul; 71(4):288-93. PubMed ID: 18463365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence based evaluation of immuno-coagulatory interventions in critical care.
    Afshari A
    Dan Med Bull; 2011 Sep; 58(9):B4316. PubMed ID: 21893014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
    Zhao Y; Grambsch PM; Neaton JD
    Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety in paediatric clinical trials--a 7-year review.
    Sammons HM; Gray C; Hudson H; Cherrill J; Choonara I
    Acta Paediatr; 2008 Apr; 97(4):474-7. PubMed ID: 18307556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical issues during the conduct of clinical trials.
    Silverman H
    Proc Am Thorac Soc; 2007 May; 4(2):180-4; discussion 184. PubMed ID: 17494728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk analysis and risk adapted on-site monitoring in noncommercial clinical trials.
    Brosteanu O; Houben P; Ihrig K; Ohmann C; Paulus U; Pfistner B; Schwarz G; Strenge-Hesse A; Zettelmeyer U
    Clin Trials; 2009 Dec; 6(6):585-96. PubMed ID: 19897532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitfalls in meta-analyses on adverse events reported from clinical trials.
    Huang HY; Andrews E; Jones J; Skovron ML; Tilson H
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1014-20. PubMed ID: 21858897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stopping clinical trials early.
    Grant A
    BMJ; 2004 Sep; 329(7465):525-6. PubMed ID: 15345605
    [No Abstract]   [Full Text] [Related]  

  • 20. American Society for Pain Management Nursing guidelines on monitoring for opioid-induced sedation and respiratory depression.
    Jarzyna D; Jungquist CR; Pasero C; Willens JS; Nisbet A; Oakes L; Dempsey SJ; Santangelo D; Polomano RC
    Pain Manag Nurs; 2011 Sep; 12(3):118-145.e10. PubMed ID: 21893302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.